Juliana Alves de Camargo

5PUBLICATIONS
28CO-AUTHORS
Molecular targetsPredictive and prognostic markersMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 08, 2026
MMP9 Knockout by CRISPR-Cas9 Reduces Bladder Cancer Malignancy But Does Not Synergize With BCG and Anti-PD-L1 in an Orthotopic Mouse Model.

|Sep 03, 2025
Interconnected study of molecular pathways: miR-137 as a central element at the intersection of lipid metabolism and prostate carcinogenesis.

Karina Serafim da Silva, Vanessa Ribeiro Guimarães, Feres Camargo Maluf

|Jun 10, 2023
Intratumoral Restoration of miR-137 Plus Cholesterol Favors Homeostasis of the miR-137/Coactivator p160/AR Axis and Negatively Modulates Tumor Progression in Advanced Prostate Cancer.

Ruan Pimenta, Carolina Mie Mioshi, Guilherme L Gonçalves

|Jan 19, 2023
Metformin acts in the gut and induces gut-liver crosstalk.

Natália Tobar, Guilherme Z Rocha, Andrey Santos

|Nov 08, 2018
MicroRNA-23b and microRNA-27b plus flutamide treatment enhances apoptosis rate and decreases CCNG1 expression in a castration-resistant prostate cancer cell line.

Ruan Ca Pimenta, Nayara I Viana, Gabriela Q Amaral

Pageof 1

Frequent Collaborators

4 joint publications

Ruan Pimenta

3 joint publications

Katia Ramos Moreira Leite

3 joint publications

Karina Serafim da Silva

2 joint publications

Iran Amorim da Silva